Back to Stakeholders

South West Sydney Local Health District (SWSLHD) is a large public health network serving south-west Sydney, New South Wales, Australia; it has participated in cutting-edge psychedelic research trials including KET-DUAL, a pilot study of ketamine-enhanced therapy for patients with co-occurring alcohol use disorder and depression, and MPATHY, an RCT of MDMA-assisted prolonged exposure therapy for comorbid alcohol use disorder and post-traumatic stress disorder.

Academic Research

0 papers

Published Papers

0

Trial Involvement

2

Distinct Focus Topics

0

Latest Publication

Unknown

Clinical Care Delivery Snapshot

Health Systems & Hospitals

Provider Model

Health System / Hospital Program

Organization Status

Unknown

Psychedelic Services

Unknown

Service Coverage

Global

Service Profile

Care Settings

Hospital Outpatient

Payer Models

Unknown

Non-Psychedelic Service Mix

Unknown

Visit Provider

Care Delivery Notes

Backfilled profile for existing L2 clinical care delivery stakeholder.

Quick Facts

Type
Other
HQ
Australia
Website
Visit

Sponsored Trials

1

Collaborated Trials

1